Results 111 to 120 of about 6,043 (171)

Levosimendan vs. Intra-Aortic Balloon Pump in Coronary Artery Bypass Grafting: A Meta-Analysis. [PDF]

Braz J Cardiovasc Surg
Wang Y, Qu J, Sheng D, Sun X, Zhong L, Wu Y, Liang H.   +6 more
europepmc   +1 more source

Depression is associated with lower adherence to cardioprotective medications in adults with type 1 diabetes. [PDF]

Acta Diabetol
Lithovius R, Mutter S, Parente EB, Harjutsalo V, Groop PH, Thorn LM, Sandholm N.   +6 more
europepmc   +1 more source

Revisiting the thrifty substrate hypothesis: Ketone bodies as cardioprotective fuels in diabetes and SGLT2 inhibitor therapy. [PDF]

J Diabetes Investig
Suzuki Y, Amano T.
europepmc   +1 more source

QSAR study on new cardiotonic agents related to milrinone

, 1994
BOGGIA, RAFFAELLA, MOSTI, LUISA, M. IESTER   +2 more
core  

Comparative Effectiveness of Ivabradine versus Digoxin in Patients with Heart Failure with Reduced Ejection Fraction and Chronic Kidney Disease: A Real-World Multicenter Cohort Study.

Cardiorenal Med
Wu JY, Lee KW, Huang SC, Chang HY, Lin YM.   +4 more
europepmc   +1 more source

Evaluation of the Anti-Mycobacterial and Anti-Inflammatory Activities of the New Cardiotonic Steroid γ-Benzylidene Digoxin-15 in Macrophage Models of Infection. [PDF]

Microorganisms
Magalhães DWA, Sidrônio MGS, Nogueira NNA, Carvalho DCM, de Freitas MEG, Oliveira EC, de Frazao Lima GF, de Araújo DAM, Scavone C, de Souza TA, Villar JAFP, Barbosa LA, Mendonça-Junior FJB, Rodrigues-Junior VS, Rodrigues-Mascarenhas S.   +14 more
europepmc   +1 more source

Targeting mitochondria to protect the heart: a matter of balance? [PDF]

Clin Sci (Lond)
Zouein FA, Booz GW.
europepmc   +1 more source

Phytochemical Profile and Biological Activity of the Ethanol Extracts from the Aerial Parts of Adonis tianschanica (Adolf.) Lipsch. Growing in Kazakhstan. [PDF]

Molecules
Orynbekova S, Kukula-Koch W, Sakipova Z, Alsharif B, Rafferty B, Nurgozhin T, Allambergenova Z, Dreher P, Głowniak K, Boylan F.   +9 more
europepmc   +1 more source

Cardiac glycosides: Looking beyond heart failure and atrial fibrillation.

Indian J Pharmacol
Omole JG, Udom GJ, Aturamu A, Agbana RD, Aziakpono OM, Oritsemuelebi B, Bukke SPN, Okon IA, Yemitan OK.   +8 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

The therapeutic potential of novel cardiotonic agents

Expert Opinion on Investigational Drugs, 2003
During the course of treatment of heart failure patients, cardiotonic agents are inevitable for improvement of myocardial dysfunction. Clinically available agents, such as beta-adrenoceptor agonists and selective phosphodiesterase 3 inhibitors, act mainly via cyclic AMP/protein kinase A-mediated facilitation of Ca(2+) mobilisation (upstream mechanism).
Masao Endoh
exaly   +3 more sources